New York City confronts a winter surge in respiratory illnesses, with a 70% increase in flu cases and ongoing COVID-19 presence, while RSV shows a slight decrease.

New York introduces 20 hours of paid prenatal leave for private-sector workers starting January 1, aiming to improve access to prenatal care without income loss.

New York hospitals are preparing for financial strain in 2025 due to expected federal funding cuts, impacting Medicare, Medicaid, and other crucial programs.

New York faces a surge in respiratory illnesses including RSV, flu, and COVID, prompting mask mandates for healthcare workers and recommendations for public precautions.

Anthem and Memorial Sloan Kettering reach an agreement to maintain in-network rates for Anthem members, ensuring continued cancer care without added financial stress.

Federal authorities have approved a tax on Managed Care Organizations in New York, a measure expected to generate significant funds for the state's Medicaid budget.

U.S. flu cases are surging with low vaccination rates reported, prompting health officials to urge vaccinations amid rising flu and other respiratory illnesses.

Funding for the World Trade Center Health Program was excluded from Congress's budget bill, eliciting disappointment from New York's fire unions and advocates for 9/11 first responders.

The NYSNA report accuses many New York hospitals of failing to comply with state law regarding nurse staffing levels, compromising patient care and safety.

New York’s Court of Appeals ruled that the city must pay for the chosen health plans of retirees, blocking an attempt to transition them to a privatized Medicare Advantage plan.

Pfizer projects 2025 revenue aligning with analysts' expectations and announces additional cost cuts amid criticisms of management and challenges such as the impact of Medicare policy changes.

NY Attorney General Letitia James declares support for medication abortion access, responding to Texas legal pressures, and reinforcing New York's commitment to reproductive health care with a protective shield law.

Protara Therapeutics raised $100 million in a public offering to fund clinical trials for its bladder cancer drug, TARA-002, and other corporate activities.